EcoDrugPlus

Ensembl ID : ENSMPUG00000019693
Gene Symbol: -
Cross references: -
136 Possible Orthologues:

Ensembl ID : ENSMPUG00000018576
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSMPUG00000011946
Gene Symbol: -
Cross references: -
418 Possible Orthologues:

Ensembl ID : ENSMPUG00000018974
Gene Symbol: -
Cross references: -
168 Possible Orthologues:

Ensembl ID : ENSMPUG00000008192
Gene Symbol: -
Cross references: -
135 Possible Orthologues:

Ensembl ID : ENSMPUG00000009988
Gene Symbol: -
Cross references: -
317 Possible Orthologues:

Ensembl ID : ENSMPUG00000019637
Gene Symbol: -
Cross references: -
145 Possible Orthologues:

Ensembl ID : ENSMPUG00000009975
Gene Symbol: -
Cross references: -
318 Possible Orthologues:

Ensembl ID : ENSMPUG00000009757
Gene Symbol: -
Cross references: -
223 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).